Christopher G. Micetich, CEO of NAEJA Pharmaceutical Awarded Special Citation for Entrepreneurial Perseverance by EY EDMONTON, Alberta, Dec. 2, 2015 (GLOBE NEWSWIRE) -- NAEJA Pharmaceutical, Inc., a pharmaceutical drug discovery and development company headquartered in Edmonton, Alberta, Canada, announced today that...

Fedora Pharmaceuticals Receives Alberta Life Sciences "Company of the Year" Award EDMONTON, Alberta, Nov. 30, 2015 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals, Inc. today announced that it was named "Company of the Year" by BioAlberta during the Association's 16th Annual General...

Fedora Pharmaceuticals Demonstrates that FPI-1465 Increases Activity of Certain Antibiotics against Drug-Resistant Bacteria EDMONTON, Alberta, Sept. 12, 2013 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals, Inc. and its collaborators presented results of preclinical studies demonstrating that FPI-1465 increases the activity of...